131 related articles for article (PubMed ID: 12124808)
1. Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients.
Rebmann V; Ugurel S; Tilgen W; Reinhold U; Grosse-Wilde H
Int J Cancer; 2002 Aug; 100(5):580-5. PubMed ID: 12124808
[TBL] [Abstract][Full Text] [Related]
2. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
[TBL] [Abstract][Full Text] [Related]
3. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U
Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692
[TBL] [Abstract][Full Text] [Related]
4. High concentration of soluble HLA-DR in the synovial fluid: generation and significance in "rheumatoid-like" inflammatory joint diseases.
Claus R; Bittorf T; Walzel H; Brock J; Uhde R; Meiske D; Schulz U; Hobusch D; Schumacher K; Witt M; Bartel F; Hausmann S
Cell Immunol; 2000 Dec; 206(2):85-100. PubMed ID: 11161440
[TBL] [Abstract][Full Text] [Related]
5. Soluble HLA-DR serum levels are associated with smoking but not with acute coronary syndrome.
Tolva J; Paakkanen R; Jarva H; Pussinen P; Havulinna AS; Salomaa V; Sinisalo J; Lokki ML
Atherosclerosis; 2017 Nov; 266():58-63. PubMed ID: 28982023
[TBL] [Abstract][Full Text] [Related]
6. Soluble HLA class I antigens in plasma of patients with malignant melanoma.
Westhoff U; Fox C; Otto FJ
Anticancer Res; 1998; 18(5B):3789-92. PubMed ID: 9854497
[TBL] [Abstract][Full Text] [Related]
7. Soluble human leukocyte antigen: a diagnostic indicator of rheumatoid arthritis?
Hayman MW; van Beijnen MT; Stamp LK; Spellerberg MB; O'Donnell JL
J Immunol Methods; 2006 Aug; 315(1-2):19-26. PubMed ID: 16893550
[TBL] [Abstract][Full Text] [Related]
8. Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients.
Ugurel S; Rappl G; Tilgen W; Reinhold U
Clin Cancer Res; 2001 May; 7(5):1282-6. PubMed ID: 11350895
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA-DR levels in serum are associated with therapy and genetic factors in rheumatoid arthritis.
Verbruggen LA; Versaen H; Rebmann V; Duquet W; De Cock S; Grosse-Wilde H; Demanet C
Hum Immunol; 2002 Sep; 63(9):758-64. PubMed ID: 12175730
[TBL] [Abstract][Full Text] [Related]
10. Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein.
Beyeler M; Waldispuhl S; Strobel K; Joller-Jemelka HI; Burg G; Dummer R
Dermatology; 2006; 213(3):187-91. PubMed ID: 17033166
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.
Sade-Feldman M; Kanterman J; Klieger Y; Ish-Shalom E; Olga M; Saragovi A; Shtainberg H; Lotem M; Baniyash M
Clin Cancer Res; 2016 Dec; 22(23):5661-5672. PubMed ID: 27178742
[TBL] [Abstract][Full Text] [Related]
12. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
[TBL] [Abstract][Full Text] [Related]
15. Influence of anticoagulants on the level of soluble HLA class I and class II antigens measured in blood samples.
Hausmann S; Claus R; Falk U; Wegener S
J Immunoassay; 1996 Aug; 17(3):257-75. PubMed ID: 8842984
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic immunoadsorption increases the level of circulating soluble HLA molecules.
Poehlau D; Kiltz U; Rieks M; Hoffmann V; Rebmann V; Schimrigk S; Grosse-Wilde H; Przuntek H
Vox Sang; 2000; 78(2):119-21. PubMed ID: 10765148
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
18. Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients.
Sanmamed MF; Fernández-Landázuri S; Rodríguez C; Lozano MD; Echeveste JI; Pérez Gracia JL; Alegre E; Carranza O; Zubiri L; Martín-Algarra S; González A
Clin Chim Acta; 2014 Feb; 429():168-74. PubMed ID: 24333389
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
Schütt P; Rebmann V; Brandhorst D; Wiefelspütz J; Ebeling P; Opalka B; Seeber S; Nowrousian MR; Moritz T; Grosse-Wilde H
Hum Immunol; 2008 Feb; 69(2):79-87. PubMed ID: 18361931
[TBL] [Abstract][Full Text] [Related]
20. Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.
Albitar M; Johnson M; Do KA; Day A; Jilani I; Pierce S; Estey E; Kantarjian H; Keating M; Verstovsek S; O'brien S; Giles FJ
Leukemia; 2007 Mar; 21(3):480-8. PubMed ID: 17215857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
